Quince Therapeutics

Quince Therapeutics, formely known as Cortexyme, focuses on precision therapeutics targeting debilitating and rare diseases.

poison pill toxic poison
Biotech

Quince adopts 'poison pill' to fend off buyout, stock purchases

The “poison pill” is intended to deter investors from accumulating stock on the open market and will kick in once they cross a threshold.
Nick Paul Taylor Apr 6, 2023 8:24am
layoffs boardroom restructuring layoff

Quince to lay off nearly half of team, sell more assets

Jan 30, 2023 6:01pm
Lighthouse

Quince's former leaders return for unwanted Alzheimer's assets

Jan 27, 2023 10:45am
quince jam fruit leaves

Quince hoping to sweeten its fruit with new strategic plan

Aug 1, 2022 10:48am